These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31179715)

  • 1. Steroidomics for highlighting novel serum biomarkers of testosterone doping.
    Ponzetto F; Boccard J; Nicoli R; Kuuranne T; Saugy M; Rudaz S
    Bioanalysis; 2019 Jun; 11(12):1171-1187. PubMed ID: 31179715
    [No Abstract]   [Full Text] [Related]  

  • 2. Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports.
    Ponzetto F; Mehl F; Boccard J; Baume N; Rudaz S; Saugy M; Nicoli R
    Anal Bioanal Chem; 2016 Jan; 408(3):705-19. PubMed ID: 26677027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.
    Ponzetto F; Parasiliti-Caprino M; Gesmundo I; Marinelli L; Nonnato A; Nicoli R; Kuuranne T; Mengozzi G; Ghigo E; Settanni F
    Talanta; 2023 Apr; 255():124218. PubMed ID: 36603442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A steroidomic approach for biomarkers discovery in doping control.
    Boccard J; Badoud F; Grata E; Ouertani S; Hanafi M; Mazerolles G; Lantéri P; Veuthey JL; Saugy M; Rudaz S
    Forensic Sci Int; 2011 Dec; 213(1-3):85-94. PubMed ID: 21831550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of Urinary and Serum Steroid Metabolites in Response to Testosterone Administration in Healthy Women.
    Elings Knutsson J; Andersson A; Baekken LV; Pohanka A; Ekström L; Hirschberg AL
    J Clin Endocrinol Metab; 2021 Mar; 106(3):697-707. PubMed ID: 33274381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution mass spectrometry as an alternative detection method to tandem mass spectrometry for the analysis of endogenous steroids in serum.
    Ponzetto F; Boccard J; Baume N; Kuuranne T; Rudaz S; Saugy M; Nicoli R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1052():34-42. PubMed ID: 28346887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted profiling of urinary steroid metabolites after testosterone ingestion: opening new perspectives for antidoping testing.
    Boccard J; Badoud F; Jan N; Nicoli R; Schweizer C; Pralong F; Veuthey JL; Baume N; Rudaz S; Saugy M
    Bioanalysis; 2014; 6(19):2523-36. PubMed ID: 25411696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of two glucuronides resistant to enzymatic hydrolysis as markers of testosterone oral administration.
    Kotronoulas A; Gomez-Gomez A; Segura J; Ventura R; Joglar J; Pozo OJ
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):212-218. PubMed ID: 27328448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of steroidomics by liquid chromatography hyphenated to mass spectrometry as a powerful analytical strategy for measuring human steroid perturbations.
    Jeanneret F; Tonoli D; Rossier MF; Saugy M; Boccard J; Rudaz S
    J Chromatogr A; 2016 Jan; 1430():97-112. PubMed ID: 26195035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive UHPLC-MS/MS method for the analysis of endogenous and exogenous steroids in serum for anti-doping purposes.
    Langer T; Salamin O; Nicoli R; Grabherr S; Kuuranne T; Musenga A
    Drug Test Anal; 2022 Nov; 14(11-12):1904-1919. PubMed ID: 36203263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
    Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
    Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.
    Badoud F; Boccard J; Schweizer C; Pralong F; Saugy M; Baume N
    J Steroid Biochem Mol Biol; 2013 Nov; 138():222-35. PubMed ID: 23796409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of doping biomarkers after administration of a single dose testosterone gel.
    Mullen J; Börjesson A; Hopcraft O; Schulze JJ; Ericsson M; Rane A; Lehtihet M; Ekström L
    Drug Test Anal; 2018 May; 10(5):839-848. PubMed ID: 29150907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports.
    Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
    Drug Test Anal; 2010; 2(11-12):582-8. PubMed ID: 21204290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of multiple biomarkers for the detection of testosterone gel administration in women with normal menstrual cycle.
    Salamin O; Nicoli R; Langer T; Boccard J; Grundisch CS; Xu C; Rudaz S; Kuuranne T; Pitteloud N; Saugy M
    Drug Test Anal; 2022 May; 14(5):833-850. PubMed ID: 33817997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
    Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and doping control.
    Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone.
    Lehtihet M; Andersson A; Börjesson A; Schulze J; Rane A; Ericsson M; Ekström L
    Drug Test Anal; 2018 Apr; 10(4):723-730. PubMed ID: 28901724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administration.
    Kotronoulas A; Gomez-Gómez À; Fabregat A; Segura J; Yang S; Xing Y; Moutian W; Marcos J; Joglar J; Ventura R; Pozo OJ
    Drug Test Anal; 2018 May; 10(5):821-831. PubMed ID: 29148228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.